Cancer in refugees in Jordan and Syria between 2009 and 2012: Challenges and the way forward in humanitarian emergencies

Paul Spiegel, Adam Khalifa, Farrah J. Mateen

Research output: Contribution to journalReview article

Abstract

Treatment of non-communicable diseases such as cancer in refugees is neglected in low-income and middle-income countries, but is of increasing importance because the number of refugees is growing. The UNHCR, through exceptional care committees (ECCs), has developed standard operating procedures to address expensive medical treatment for refugees in host countries, to decide on eligibility and amount of payment. We present data from funding applications for cancer treatments for refugees in Jordan between 2010 and 2012, and in Syria between 2009 and 2011. Cancer in refugees causes a substantial burden on the health systems of the host countries. Recommendations to improve prevention and treatment include improvement of health systems through standard operating procedures and innovative financing schemes, balance of primary and emergency care with expensive referral care, development of electronic cancer registries, and securement of sustainable funding sources. Analysis of cancer care in low-income refugee settings, particularly in sub-Saharan Africa, is needed to inform future responses.

Original languageEnglish (US)
JournalThe Lancet Oncology
Volume15
Issue number7
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Syria
Jordan
Refugees
Emergencies
Neoplasms
United Nations
Africa South of the Sahara
Health
Emergency Medical Services
Therapeutics
Registries
Primary Health Care
Referral and Consultation

ASJC Scopus subject areas

  • Oncology

Cite this

Cancer in refugees in Jordan and Syria between 2009 and 2012 : Challenges and the way forward in humanitarian emergencies. / Spiegel, Paul; Khalifa, Adam; Mateen, Farrah J.

In: The Lancet Oncology, Vol. 15, No. 7, 2014.

Research output: Contribution to journalReview article

@article{580ebf1f5da443eb91290fe46424604d,
title = "Cancer in refugees in Jordan and Syria between 2009 and 2012: Challenges and the way forward in humanitarian emergencies",
abstract = "Treatment of non-communicable diseases such as cancer in refugees is neglected in low-income and middle-income countries, but is of increasing importance because the number of refugees is growing. The UNHCR, through exceptional care committees (ECCs), has developed standard operating procedures to address expensive medical treatment for refugees in host countries, to decide on eligibility and amount of payment. We present data from funding applications for cancer treatments for refugees in Jordan between 2010 and 2012, and in Syria between 2009 and 2011. Cancer in refugees causes a substantial burden on the health systems of the host countries. Recommendations to improve prevention and treatment include improvement of health systems through standard operating procedures and innovative financing schemes, balance of primary and emergency care with expensive referral care, development of electronic cancer registries, and securement of sustainable funding sources. Analysis of cancer care in low-income refugee settings, particularly in sub-Saharan Africa, is needed to inform future responses.",
author = "Paul Spiegel and Adam Khalifa and Mateen, {Farrah J.}",
year = "2014",
doi = "10.1016/S1470-2045(14)70067-1",
language = "English (US)",
volume = "15",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "7",

}

TY - JOUR

T1 - Cancer in refugees in Jordan and Syria between 2009 and 2012

T2 - Challenges and the way forward in humanitarian emergencies

AU - Spiegel, Paul

AU - Khalifa, Adam

AU - Mateen, Farrah J.

PY - 2014

Y1 - 2014

N2 - Treatment of non-communicable diseases such as cancer in refugees is neglected in low-income and middle-income countries, but is of increasing importance because the number of refugees is growing. The UNHCR, through exceptional care committees (ECCs), has developed standard operating procedures to address expensive medical treatment for refugees in host countries, to decide on eligibility and amount of payment. We present data from funding applications for cancer treatments for refugees in Jordan between 2010 and 2012, and in Syria between 2009 and 2011. Cancer in refugees causes a substantial burden on the health systems of the host countries. Recommendations to improve prevention and treatment include improvement of health systems through standard operating procedures and innovative financing schemes, balance of primary and emergency care with expensive referral care, development of electronic cancer registries, and securement of sustainable funding sources. Analysis of cancer care in low-income refugee settings, particularly in sub-Saharan Africa, is needed to inform future responses.

AB - Treatment of non-communicable diseases such as cancer in refugees is neglected in low-income and middle-income countries, but is of increasing importance because the number of refugees is growing. The UNHCR, through exceptional care committees (ECCs), has developed standard operating procedures to address expensive medical treatment for refugees in host countries, to decide on eligibility and amount of payment. We present data from funding applications for cancer treatments for refugees in Jordan between 2010 and 2012, and in Syria between 2009 and 2011. Cancer in refugees causes a substantial burden on the health systems of the host countries. Recommendations to improve prevention and treatment include improvement of health systems through standard operating procedures and innovative financing schemes, balance of primary and emergency care with expensive referral care, development of electronic cancer registries, and securement of sustainable funding sources. Analysis of cancer care in low-income refugee settings, particularly in sub-Saharan Africa, is needed to inform future responses.

UR - http://www.scopus.com/inward/record.url?scp=84901473977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901473977&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(14)70067-1

DO - 10.1016/S1470-2045(14)70067-1

M3 - Review article

C2 - 24872112

AN - SCOPUS:84901473977

VL - 15

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 7

ER -